(Q40874080)

24 September 2017

title

Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals (English)

1 reference

24 September 2017

0 references

E Lee

1

1 reference

24 September 2017

T Robertson

series ordinal

2

1 reference

24 September 2017

J Smith

series ordinal

3

1 reference

24 September 2017

S Kilfeather

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

161

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1881-1886

1 reference

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Granulocyte clearance by apoptosis in the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Human eosinophils prefernentially surivive on tissue fibronectin compared with plasama fibronection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Leukotriene B4 in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Arachidonic acid metabolism in the human mast cell line HMC-1: 5-lipoxygenase gene expression and biosynthesis of thromboxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9907054

10.1164/AJRCCM.161.6.9907054

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference